Corrigendum to "Chlorambucil-conjugated PI-polyamide (Chb-M'), a transcription inhibitor of the RUNX family, has anti-tumor activity against SHH-type medulloblastoma with p53 mutation" [Biochem. Biophys. Res. Commun. 620 (10 September 2022) 150-157]
Biochem Biophys Res Commun. 2023 May 14:656:146-147.
doi: 10.1016/j.bbrc.2023.03.022.
Epub 2023 Mar 23.
1 Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
2 Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan; Department of Artificial Intelligence in Healthcare and Medicine, Kyoto University, Kyoto, 606-8507, Japan.
3 Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
4 Department of Pediatrics, Graduate School of Medicine, Kyoto University, 606-8507, Kyoto, Japan.
5 Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto City, Kyoto, 606-8507, Japan.
6 Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
7 Department of Chemistry, Graduate School of Science, Kyoto University, Kyoto, 606-8502, Japan. Electronic address: hs@kuchem.kyoto-u.ac.jp.
8 Department of Neurosurgery, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan. Electronic address: yarakawa@kuhp.kyoto-u.ac.jp.
9 Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan. Electronic address: kamikubo.yasuhiko.7u@kyoto-u.ac.jp.